Centro de Investigación Pergamino S.A
Nuestro equipo trabaja de manera colaborativa y multidisciplinaria para ofrecer un enfoque integral en el cuidado de la salud y la investigación médica. Estamos comprometidos en brindar a nuestros pacientes, la mejor atención posible y contribuir al avance de la medicina.Av. de Mayo 1115, Pergamino, Buenos Aires
Websitehttps://cip.com.ar/
Select an option
I am a doctor
I am a sponsor
Specializations
Oncología
Patients Benefits
Los estudios clínicos que están bien diseñados y bien ejecutados son el mejor enfoque para los participantes elegibles para: a. Ayudar a los demás, contribuyendo a la investigación médica b. Desempeñar un papel activo en su propia atención médica.
Our team
Medical staff
Investigadora Principal
Oncóloga Clínica - RadioterapeutaSusana Kahl
OncólogaLucia Fabiano
Médica ClínicaMaría Florencia Chamut
Médica ClínicaAna Josefina Masciotta
Legal and Administrative staff
CoordinadorDonato Cignoli
CoordinadorFlorencia Hidalgo
CoordinadorCamila Ludueña
CoordinadorValentin Parra
Open studies
Lung cancer
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations - TROPION-Lung08 - AstraZenecaSee more
Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC - MB12-C-01-22 - Laboratorio Elea Phoenix S.A.See more
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) - TROPION-Lung07 - AstraZenecaSee more
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 - KRYSTAL-7 - Mirati Therapeutics Inc.See more
A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer - MARYGOLD - AmgenSee more
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) - ABBIL1TY NSCLC-06 - GenmabSee more
Colorectal cancer
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer - MOUNTAINEER-03 - Seagen Inc.See more
Gastric cancer
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer - Henlius USASee more
Gastroesophageal cancer
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer - Henlius USASee more
Head and neck cancer
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 - AHEAD-MERIT - BioNTech SESee more
Urothelial cancer
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 - KEYNOTE-D74 - Seagen Inc.See more
